-
Ad-hoc-Mitteilung gem盲ss Art. 53 KR Pratteln, Schweiz, 19.聽Juli 2023 鈥� Santhera Pharmaceuticals (SIX: SANN) gibt den Abschluss der exklusiven Lizenzvereinbarung f眉r Vamorolone in Nordamerika (NA) mit...
-
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, July聽19, 2023 鈥� Santhera Pharmaceuticals (SIX: SANN) announces the closing of the exclusive license agreement for vamorolone in North...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Ad-hoc-Mitteilung gem盲ss Art. 53 KR Pratteln, Schweiz, 29.聽Juni...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Ad hoc announcement pursuant to Art. 53 LR Pratteln,...
-
Pratteln, Schweiz, 27. Juni 2023 鈥� Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass die Aktion盲re an der heutigen Generalversammlung (GV) in Pratteln, Schweiz, allen Antr盲gen des...
-
Pratteln, Switzerland, June聽27, 2023 鈥� Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders approved all motions by the Board of Directors at the Annual General Meeting (AGM) held...
-
Ad-hoc-Mitteilung gem盲ss Art. 53 KR Santhera wird heute um 14:30 MESZ / 13:30 BST / 08:30 EDT eine Telefonkonferenz durchf眉hren. Details dazu am Ende dieser Mitteilung. Santhera erh盲lt USD聽90...
-
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held today at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Santhera will receive USD...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Ad-hoc-Mitteilung gem盲ss Art. 53 KR Pratteln, Schweiz, 6. Juni...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland,...